Tessera Therapeutics Revenue and Competitors

Boston, MA USA

Location

$431.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tessera Therapeutics's estimated annual revenue is currently $70.4M per year.(i)
  • Tessera Therapeutics's estimated revenue per employee is $155,000
  • Tessera Therapeutics's total funding is $431.8M.
  • Tessera Therapeutics's current valuation is $1.7B. (April 2022)

Employee Data

  • Tessera Therapeutics has 454 Employees.(i)
  • Tessera Therapeutics grew their employee count by 24% last year.

Tessera Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
General Counsel and SecretaryReveal Email/Phone
3
SVP Finance and Corporate ControllerReveal Email/Phone
4
SVP, Head Therapeutic Discovery and Translational SciencesReveal Email/Phone
5
SVP, Head Corporate DevelopmentReveal Email/Phone
6
VP, IP & Legal AffairsReveal Email/Phone
7
Head PharmacologyReveal Email/Phone
8
Head HRISReveal Email/Phone
9
SVP, Technical Operations - CMC Development and ManufacturingReveal Email/Phone
10
VP, Investor Relations and Strategic FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Tessera Therapeutics?

Our mission is to cure disease by writing the code of life

keywords:N/A

$431.8M

Total Funding

454

Number of Employees

$70.4M

Revenue (est)

24%

Employee Growth %

$1.7B

Valuation

N/A

Accelerator

Tessera Therapeutics News

2022-04-17 - Tessera Therapeutics Raises Over $300M in Series C Financing

Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding.

2022-04-17 - Tessera Therapeutics stacks up more than $300M in series C funds ...

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million...

2022-04-17 - Tessera Therapeutics Announces Over $300M Series C Financing ...

Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$99.8M4568%N/A
#2
$35M4567%N/A
#3
$81.6M459-11%$502.5M
#4
$58.7M460N/AN/A
#5
$93.1M4636%N/A